Ying Wang

Ying Wang's practice focuses on M&A, foreign direct investment, joint ventures, and other types of cross-border transactions involving China. She advises multinational clients and investors on structuring potential and existing investments and operations in China. She also has experience advising U.S. companies on FCPA and anti-monopoly law issues relating to their China operations.

Ying works with clients in various industries including pharmaceuticals, machinery, aviation, energy resources, life sciences, automotive, chemicals, consulting, e-commerce, and financial services. Recent matters include assisting a number of Fortune 500 multinational corporations in their equity and asset acquisitions, mergers, financings, and restructuring projects involving China; assisting foreign investors in setting up joint ventures and wholly owned subsidiaries in China; and conducting investigations for multinationals regarding FCPA and PRC anti-bribery law compliance. [1]